DXS InternationalSTU:7EE 39 PB Ratio is 1.57 as of Jul. 08, 2026, which is 10% above its 10-year median of 1.43. GuruFocus rates STU:7EE with a GF Score™ of 39/100 and a GF Value™ of €0.02. The stock has 2 warning signs investors should review. Among 607 Healthcare Providers & Services companies, DXS International ranks worse than 54.53% on this metric.
The historical rank and industry rank for DXS International's PB Ratio or its related term are showing as below:
STU:7EE'
s PB Ratio Range Over the Past 10 Years
Min: 0.14 Med: 1.43 Max: 4.64
Current: 2.08
During the past 11 years, DXS International's highest PB Ratio was 4.64. The lowest was 0.14. And the median was 1.43.
STU:7EE's PB Ratio is ranked worse than 54.53% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 2.02
vs STU:7EE: 2.08
During the past 12 months, DXS International's average Book Value Per Share Growth Rate was -14.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -59.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -43.80% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -11.50% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of DXS International was 25.30% per year. The lowest was -59.50% per year. And the median was 9.35% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
DXS International PB Ratio Related Terms
DXS International PB Ratio Historical Data
* Premium members only.
The historical data trend for DXS International's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, DXS International's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's PB Ratio distribution charts can be found below:
* The bar in red indicates where DXS International's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
DXS International (STU:7EE) has a PB Ratio of 1.57 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on DXS International and its competitors. This is 10% above median its historical median of 1.43. Over the past decade, DXS International's PB Ratio has ranged from 0.14 to 4.64. According to the industry distribution chart, DXS International ranks #331 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 54.5%.
Is DXS International's PB Ratio too high?
DXS International's current PB Ratio of 1.57 is 10% above median its 10-year median of 1.43. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 4.64. The Healthcare Providers & Services industry median PB Ratio is 2.02. DXS International's value of 1.57 is 22.3% below this industry median. Based on the distribution chart, DXS International ranks #331 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, DXS International has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does DXS International's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #331 out of 607 companies for PB Ratio. This places DXS International in the lower half of its industry. The industry median PB Ratio is 2.02. DXS International's value of 1.57 is 22.3% below this benchmark. Historically, DXS International's own PB Ratio has ranged from 0.14 to 4.64 over the past decade. While the company's 10-year median is 1.43 vs. the industry median of 2.02, DXS International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.02, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DXS International's current PB Ratio of 1.57 is 22.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current PB Ratio is 1.57, which is 10% above median its own 10-year median of 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
DXS International (STU:7EE) has a current PB Ratio of 1.57. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 45% below its estimated fair value. The current PB Ratio is 1.57, which is 10% above median its 10-year median of 1.43 and 22.3% below the Healthcare Providers & Services industry median of 2.02. DXS International's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For DXS International (STU:7EE), the current PB Ratio is 1.57 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DXS International (STU:7EE) Overvalued in 2026?
Based on GuruFocus' analysis, DXS International stock appears to be undervalued.
The current stock price of €0.01 is trading 45% below its estimated GF Value™ of €0.02.
Key valuation signals for STU:7EE:
PB Ratio: 1.57 (10% above median its 10-year median of 1.43)
GF Value™: €0.02 vs. price of €0.01 (45% below fair value)
Industry Position: 22.3% below the Healthcare Providers & Services median (#331 of 607)
No single metric tells the full story. See the STU:7EE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
39GF Score
Get the complete analysis for STU:7EE
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:7EE has been successfully added to your 
